Clinical Trials
3 trialsNCT03745989 2023-07-27
MK-8353-014
Merck Sharp & Dohme LLC
Phase 1 Completed
NCT01809210 2018-03-13
SELECT-3
AstraZeneca
Phase 1 Completed
NCT01605916 2016-10-21
Investigate the Safety and Tolerability of AZD6244 Monotherapy or + Docetaxel in Japanese Patients With Advanced Solid Malignancies or Non-Small Cell Lung Cancer
AstraZeneca
Phase 1 Completed